
GlaxoSmithKline (GSK) Market Capitalization Overview
Market Cap: $78.98B as of Jul 9, 2025
$78.98B
Past Month-$4.57B (5.46%)
As of Jul 9, 2025, GlaxoSmithKline (GSK) has a market capitalization of $78.98B. Over the past 30 days, its market cap has decreased by -6.58%, while in the last 12 months, it has increased by 14.45%.
Market capitalization represents the total value of GlaxoSmithKline as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
GlaxoSmithKline (GSK) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of GlaxoSmithKline (GSK) helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of GlaxoSmithKline as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
GlaxoSmithKline (GSK) Market Cap Formula = Stock Price * Shares Outstanding
The market cap of GlaxoSmithKline (GSK) helps investors assess the company's size and compare it with competitors for better investment decisions.
GlaxoSmithKline (GSK) Market Cap & Key Trends
See GlaxoSmithKline’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in GlaxoSmithKline (GSK)
Order type
Buy in
Order amount
Est. shares
0 shares
GlaxoSmithKline (GSK) Market Cap History
Date | Market Cap | Change |
---|---|---|
Jul 1, 2025 | $78.85B | -6.58% |
Jun 2, 2025 | $84.41B | +7.51% |
May 1, 2025 | $78.51B | +1.92% |
Apr 1, 2025 | $77.03B | -0.51% |
Mar 3, 2025 | $77.42B | +8.72% |
Feb 3, 2025 | $71.21B | +2.80% |
Jan 2, 2025 | $69.27B | -1.05% |
GlaxoSmithKline (GSK) End of Year Market Cap History
Date | Market Cap | Change |
---|---|---|
2025 | $78.98B | +14.45% |
2024 | $69.01B | -8.64% |
2023 | $75.54B | +5.86% |
2022 | $71.36B | -21.45% |
2021 | $90.85B | +20.50% |
2020 | $75.39B | — |
FAQs About GlaxoSmithKline (GSK) Market Cap
As of Jul 9, 2025, the market capitalization of GlaxoSmithKline (GSK) is $78.98B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, GlaxoSmithKline’s market capitalization has decreased by -5.46%, changing from $83.54B to $78.98B as of Jul 9, 2025.
In the last 3 months, GlaxoSmithKline’s market capitalization has increased by —, changing from – to – as of –.
In the year 2024, GlaxoSmithKline’s market capitalization decreased from $75.54B in January to $69.01B in December, reflecting a -8.64% change.
In the past five years, GlaxoSmithKline (GSK) has had a compound annual growth rate (CAGR) of -1.75% in market capitalization. This means its market cap has shrunk at an average rate of -1.75% per year.